104 related articles for article (PubMed ID: 8332607)
1. A vector projection approach to predicting HIV protease cleavage sites in proteins.
Chou KC; Zhang CT; Kézdy FJ
Proteins; 1993 Jun; 16(2):195-204. PubMed ID: 8332607
[TBL] [Abstract][Full Text] [Related]
2. Support Vector Machines for predicting HIV protease cleavage sites in protein.
Cai YD; Liu XJ; Xu XB; Chou KC
J Comput Chem; 2002 Jan; 23(2):267-74. PubMed ID: 11924738
[TBL] [Abstract][Full Text] [Related]
3. Predicting human immunodeficiency virus protease cleavage sites in proteins by a discriminant function method.
Chou KC; Tomasselli AG; Reardon IM; Heinrikson RL
Proteins; 1996 Jan; 24(1):51-72. PubMed ID: 8628733
[TBL] [Abstract][Full Text] [Related]
4. Prediction of human immunodeficiency virus protease cleavage sites in proteins.
Chou KC
Anal Biochem; 1996 Jan; 233(1):1-14. PubMed ID: 8789141
[TBL] [Abstract][Full Text] [Related]
5. An alternate-subsite-coupled model for predicting HIV protease cleavage sites in proteins.
Zhang CT; Chou KC
Protein Eng; 1994 Jan; 7(1):65-73. PubMed ID: 8140096
[TBL] [Abstract][Full Text] [Related]
6. A vector projection method for predicting the specificity of GalNAc-transferase.
Chou KC; Zhang CT; Kézdy FJ; Poorman RA
Proteins; 1995 Feb; 21(2):118-26. PubMed ID: 7777486
[TBL] [Abstract][Full Text] [Related]
7. Predicting cleavability of peptide sequences by HIV protease via correlation-angle approach.
Chou JJ
J Protein Chem; 1993 Jun; 12(3):291-302. PubMed ID: 8397787
[TBL] [Abstract][Full Text] [Related]
8. A formulation for correlating properties of peptides and its application to predicting human immunodeficiency virus protease-cleavable sites in proteins.
Chou JJ
Biopolymers; 1993 Sep; 33(9):1405-14. PubMed ID: 8400033
[TBL] [Abstract][Full Text] [Related]
9. Kinetic and modeling studies of S3-S3' subsites of HIV proteinases.
Tözsér J; Weber IT; Gustchina A; Bláha I; Copeland TD; Louis JM; Oroszlan S
Biochemistry; 1992 May; 31(20):4793-800. PubMed ID: 1591240
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 protease cleavage site prediction based on amino acid property.
Niu B; Lu L; Liu L; Gu TH; Feng KY; Lu WC; Cai YD
J Comput Chem; 2009 Jan; 30(1):33-9. PubMed ID: 18496789
[TBL] [Abstract][Full Text] [Related]
11. A sequence-coupled vector-projection model for predicting the specificity of GalNAc-transferase.
Chou KC
Protein Sci; 1995 Jul; 4(7):1365-83. PubMed ID: 7670379
[TBL] [Abstract][Full Text] [Related]
12. Studies on the specificity of HIV protease: an application of Markov chain theory.
Chou KC; Zhang CT
J Protein Chem; 1993 Dec; 12(6):709-24. PubMed ID: 8136021
[TBL] [Abstract][Full Text] [Related]
13. Development of pseudopeptide inhibitors of HIV-1 aspartic protease: analysis and tuning of the subsite specificity.
Tossi A; Antcheva N; Romeo D; Miertus S
Pept Res; 1995; 8(6):328-34. PubMed ID: 8838416
[TBL] [Abstract][Full Text] [Related]
14. Identification of efficiently cleaved substrates for HIV-1 protease using a phage display library and use in inhibitor development.
Beck ZQ; Hervio L; Dawson PE; Elder JH; Madison EL
Virology; 2000 Sep; 274(2):391-401. PubMed ID: 10964781
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 Protease Uses Bi-Specific S2/S2' Subsites to Optimize Cleavage of Two Classes of Target Sites.
Potempa M; Lee SK; Kurt Yilmaz N; Nalivaika EA; Rogers A; Spielvogel E; Carter CW; Schiffer CA; Swanstrom R
J Mol Biol; 2018 Dec; 430(24):5182-5195. PubMed ID: 30414407
[TBL] [Abstract][Full Text] [Related]
16. A vectorized sequence-coupling model for predicting HIV protease cleavage sites in proteins.
Chou KC
J Biol Chem; 1993 Aug; 268(23):16938-48. PubMed ID: 8349584
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the P2' and P3' specificities of thrombin using fluorescence-quenched substrates and mapping of the subsites by mutagenesis.
Le Bonniec BF; Myles T; Johnson T; Knight CG; Tapparelli C; Stone SR
Biochemistry; 1996 Jun; 35(22):7114-22. PubMed ID: 8679538
[TBL] [Abstract][Full Text] [Related]
18. Artificial neural network method for predicting HIV protease cleavage sites in protein.
Cai YD; Yu H; Chou KC
J Protein Chem; 1998 Oct; 17(7):607-15. PubMed ID: 9853675
[TBL] [Abstract][Full Text] [Related]
19. A cumulative specificity model for proteases from human immunodeficiency virus types 1 and 2, inferred from statistical analysis of an extended substrate data base.
Poorman RA; Tomasselli AG; Heinrikson RL; Kézdy FJ
J Biol Chem; 1991 Aug; 266(22):14554-61. PubMed ID: 1860861
[TBL] [Abstract][Full Text] [Related]
20. Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1.
Barrie KA; Perez EE; Lamers SL; Farmerie WG; Dunn BM; Sleasman JW; Goodenow MM
Virology; 1996 May; 219(2):407-16. PubMed ID: 8638406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
